Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185367
Status:
COMPLETED
Last Update Posted:
2011-07-15
First Post:
2005-09-13
Brief Title:
Comparative Cycle Control Europe
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
A Multi-center Double-blind Double-dummy Controlled Randomized Study to Evaluate Cycle Control and Safety of a Four Phasic Oral Contraceptive SH T00658ID in Comparison to an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel SH D 593 B in Healthy Female Volunteers Aged Between 18 and 50 Years
Status:
COMPLETED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to evaluate bleeding pattern cycle control and safety of this new four-phasic oral contraceptive in comparison to a reference OC
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG GermanyBayer Schering Pharma AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 304004 | None | None | None |
| EudraCT 2004-001613-34 | None | None | None |